UNSPSC 51373447: Codeine/menthol/pheniramine/phenylephrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373447 Codeine/menthol/pheniramine/phenylephrine (Commodity) covers pharmaceutical products and related delivery services for state and local healthcare and public-health operations. The actual work solicited under this code spans parenteral nutrition solutions, intravenous products, naloxone, and drug deactivation systems procured by corrections agencies, county health departments, and other public entities to support incarcerated populations and community health initiatives. Issuing bodies include state departments of corrections and county health agencies. The scope extends beyond single-product procurement to encompass delivery logistics, patient-monitoring services, and equipment systems — Washington State Department of Corrections solicitation RFQQK13020 required bidders to demonstrate documented experience preparing and delivering IV solutions, monitoring patient lab results, and adjusting parenteral nutrition preparations, with strict delivery timelines (PN bags within 24 hours, other parenteral products within 8 hours). Set-aside and preference programs vary by buyer: Washington State DOC targets 25% small business, 10% minority-owned, 6% women-owned, and 5% veteran-owned participation under state law, with an aspirational 5% Small and Diverse Business Goal and subcontractor-inclusion requirements.

Recent activity clusters in Washington State and Florida. Washington State Department of Corrections issued RFQ RFQQK13020 in September 2026 for parenteral products and services to eight correctional facilities across the state, with a response deadline of October 7, 2026, and anticipated awards to up to three bidders per region (West, Central, and East) under a contract running November 26, 2026 through June 30, 2030. Seminole County, Florida issued IFB 60459723LAS in June 2026 for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building, though the response deadline cited in the source (July 26, 2023) appears outdated relative to the June 2026 posting date. Both jurisdictions require vendor compliance with insurance, business-licensure, background-check, and E-Verify standards. The code shows limited recent activity; these two opportunities represent the available market signal.